News Follow-Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center

2021/11/08

Pingshan Center and Thermo Fisher signed a strategic cooperation agreement to jointly build the Shenzhen Bay Laboratory - Thermo Fisher Research Platform

On November 6, Shenzhen Bay Laboratory Pingshan Biomedical R&D and Transformation Center (hereinafter referred to as "Pingshan Center") and Thermo Fisher Scientific Co., Ltd. (hereinafter referred to as "Thermo Fisher") signed a strategic cooperation agreement in Shanghai. Both sides will conduct in-depth cooperation in the fields of high-end mass spectrometry equipment and technical services, and jointly build the Shenzhen Bay Laboratory - Thermo Fisher Research Platform.

2021/10/23

Open Day | Agilent Special Biopharmaceutical Analysis Technology Seminar

On the morning of October 22, cold air arrived without an appointment. However, in the Lecture hall on the 14th floor of Block B of Pingshan High tech Zone Industry University Research Base, the enthusiasm was fiery and the temperature was not decreasing. The opening day of Pingshan Center in October was held as scheduled. This event invited technical experts from Agilent Technologies (China) Co., Ltd. to discuss "biopharmaceutical analytical technology". After Li Zigang, executive director of Pingshan Center, gave a welcome speech, The technical managers of Agilent Technologies brought wonderful speeches and had a heated discussion with the audience.

2021/09/29

Academician and Expert Tour Team of "Science and China" Enters Pingshan Center

On the afternoon of September 27th, an academician and expert delegation from "Science and China" visited the Pingshan Biomedical Research and Transformation Center at the Shenzhen Bay Laboratory for on-site inspection.

2021/09/23

Research progress has been made in the development of peptide based nuclide conjugated drugs through cooperation between Shenzhen Bay Laboratory Pingshan Center and Japan's National Institute of Measurement and Research

Recently, Li Zigang's research group published a report on Acta Pharmaceutica Sinica B, a Medicinal chemistry journal (Chinese name: Journal of Pharmacy, the leading journal of excellent action plan of Chinese scientific and technological journals, IF=11.413),

2021/09/18

Open Day | Shimadzu Special Session, Technological Progress Brings Biopharmaceuticals on the Wings of Ascension

On September 17th, the new Pingshan Center Open Day was held on the 14th floor of the Pingshan New Area Industry University Research Base. The theme of this open day event was "Biopharmaceutical Analysis and Synthesis Sharing Meeting". The technical managers of Shimadzu Company introduced the new applications of analytical technology in the field of biopharmaceuticals, and the R&D personnel of Jianyuan Company demonstrated the important role of analytical technology in chemical synthesis through specific synthesis cases.

2021/09/17

SZBL Happy Hour Academic Exchange Conference Teacher's Day Special Event - "Walking into Pingshan"

On September 10th, the SZBL Happy Hour Academic Exchange Conference held a special event for Teachers' Day - "Walking into Pingshan", which held academic exchanges and visited representative pharmaceutical enterprises in Pingshan Center and the park. Senior laboratory researcher Li Zigang and National Application Manager Guo Lihai of SCIEX Company gave special reports, with over 50 representatives from various research institutes/centers and related enterprises in the laboratory participating.

2021/09/17

Employee Birthday Party | Along the Path of Growth, We Come Together

On September 3rd, Pingshan Center held an employee birthday party for the first half of 2021.

2021/09/17

Research Trends | Pingshan Center and Bayer Pharmaceuticals Targeting HIF1 α Research progress in the development of peptide inhibitors for p300 interactions

Zi Gang/Yin Feng's research group published the journal of Medicinal chemistry entitled "Potential invasion of HIF1 α And p300 interaction by a constrained perspective derived from CITED2 "research paper. This study uses the helix induced stable peptide method of terminal Aspartic acid,

2021/09/17

Exploring new mechanisms for clinical research cooperation, this exchange will not be simple

On August 24th, Pingshan Center held an academic exchange meeting on the 14th floor of the industry university research base. The meeting was attended by representatives of the Shenzhen Municipal Committee of the CPPCC, the Zhigong Party, Shenzhen Second People's Hospital, Shenzhen Corning Hospital, Southern University of Science and Technology, Chinese Academy of Sciences Shenzhen Institute of Advanced Technology, Shenzhen Bay Laboratory and other units. The conference focuses on the transformation of policies, technologies, platforms, talents, and research achievements, delves into the scientific innovation path of biopharmaceuticals, deepens the cooperation between industry, academia, research and medicine, and jointly assists the development of the biopharmaceutical industry in Shenzhen and even the Greater Bay Area.